Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Legal Issues Deals Strategy

R&D Collaborations: A Legal Route Map

Executive Summary

Collaboration is an essential feature of R&D, but navigating the legal landscape can be daunting. Lawyers Charlotte Tillett and Astrid Arnold outline some of the key issues that R&D partners need to consider to safeguard their interests and provide a smooth start for their partnership.

You may also be interested in...



Trade Secret Theft: What Will The New EU Legislation Bring?

Following the recent introduction of enhanced trade secrets protection in both the EU and the US, UK attorneys Charlotte Tillett and Astrid Arnold consider what difference the new European Trade Secrets Directive will make, the impact of Brexit and how life sciences companies can improve their position.

Table

View full table

Topics

Related Companies

Tags:
Legal Issues Deals Strategy
Latest Headlines

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout

Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches

Precision Keeps Faith In Duchenne Gene-Editing After Lilly’s Exit

See All
UsernamePublicRestriction

Register

SC065128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By